← Pipeline
Registered human trialRecruitingNo efficacy data yet
Phase 2
Metformin in aging MS
Metformin • ages 55–75
Practical availability: Research study — recruiting does not guarantee access
- Compound / intervention
- Metformin • ages 55–75
- Mechanism
- Metformin; age-related repair biology
- Development stage
- Phase 2
- Status
- Recruiting • NCT06463743
- Population / locations
- Site: Buffalo, US • no Greek site
- Evidence level
- Human Phase 2 • results pending
Next substantive checkpoint
Safety plus MRS/MRI, myelin-water-fraction and neuroprotection or repair readouts
Related substantive developments
No separate substantive update is currently linked.